A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections.
Starting soon · Not applicable · Has a placebo group
Conditions studied: Bacterial Vaginosis, Yeast Infection
In brief
This virtual randomized controlled trial evaluates the efficacy of a prebiotic and probiotic supplement in providing relief from symptoms associated with bacterial vaginosis and yeast infections. Participants will be randomized into three groups-test product, active placebo, and excipient placebo-and will take two capsules daily for 30 days. The study will assess the effects on vaginal microbiome, symptoms of bacterial vaginosis and yeast infections, and overall vaginal health.
Key facts
- Study ID
- NCT06665126
- Run by
- Happy V
- People needed
- 120
- Starts
- 2024-11-01
- Expected to finish
- 2025-05-30
- Last updated by the study team
- 2024-10-30
Who can join
Age: 25 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women
- Age 25+
- Self-reported concerns symptoms associated with bacterial vaginosis or candida overgrowth, including itchiness, redness, abnormal discharge, and an unpleasant odor.
- Suffers from digestive issues, including bloating, gas, or other digestive discomfort.
- Generally healthy - do not live with any uncontrolled chronic diseases.
- Willing to avoid using any vaginal health-related medications, supplements, and herbal remedies for the duration of this study.
- If taking oral supplements or herbal remedies targeted at vaginal health, has been consistently taking these for at least 3 months prior to starting the study and is willing to maintain this routine for the study duration.
You may not qualify if…
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Planning to undergo any procedure related to their vaginal health.
- Started any new medications or supplements that target vaginal health in the past 3 months.
- Anyone with known severe allergic reactions that require the use of an Epi-Pen, or any known allergies to any of the product ingredients
- Women who are pregnant, breastfeeding, or attempting to conceive
- Unwilling to follow the study protocol
- Anyone who has undergone any surgeries or invasive treatments in the last three months or has any planned during the study period.
Where it is running
- Citruslabs — Santa Monica, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.